Suchergebnisse - "Auerbach, Michael"

PubPharm (220)

21

RAPIDIRON : Reducing Anaemia in Pregnancy in India-a 3-arm, randomized-controlled trial comparing the effectiveness of oral iron with single-dose intravenous iron in the treatment of iron deficiency anaemia in pregnant women and reducing low birth weight deliveries

enthalten in: Trials | 2021

von Derman, R. | Goudar, S. | Thind, S. | +37

22

RAPIDIRON: Reducing Anaemia in Pregnancy in India—a 3-arm, randomized-controlled trial comparing the effectiveness of oral iron with single-dose intravenous iron in the treatment of iron deficiency anaemia in pregnant women and reducing low birth weight deliveries

enthalten in: Trials | 2021

von Derman, R. | Goudar, S. | Thind, S. | +27

23

RAPIDIRON: Reducing Anaemia in Pregnancy in India A 3-Arm, Randomized-Controlled Trial Comparing The Effectiveness of Oral Iron With Single-Dose Intravenous Iron In The Treatment of Iron Deficiency Anaemia In Pregnant Women And Reducing Low Birth Weight Deliveries.

enthalten in: ResearchSquare.com | 2021

von Derman, R. | Goudar, S. | Thind, S. | +27

24

Intravenous ferric derisomaltose for the treatment of iron deficiency anemia

enthalten in: American journal of hematology | 2021

von Auerbach, M. | Henry, D. | DeLoughery, T.

25

Using Reticulocyte Hemoglobin Equivalent as a Marker for Iron Deficiency and Responsiveness to Iron Therapy

enthalten in: Mayo Clinic proceedings | 2021

von Auerbach, M. | Staffa, S. | Brugnara, C.

26

Comment on : Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System

enthalten in: Drug safety | 2021

von Auerbach, M.

CommentOn: Drug Saf. 2021 Jan;44(1):107-119. - PMID 33237523

27

Comment on: Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System

enthalten in: Drug safety | 2021

von Auerbach, M.

28

Comment on: Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System

enthalten in: Drug safety | 2021

von Auerbach, M.

29

Comment on: Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System

enthalten in: Drug safety | 2021

von Auerbach, M.

30

Preoperative Intravenous Iron in Anemic Patients Undergoing Major Abdominal Surgery May Not PREVENTT Blood Transfusions But Still Contribute to the Objectives of Patient Blood Management

enthalten in: Anesthesia and analgesia | 2021

von Hardy, J. | Farmer, S. | Auerbach, M. | +6